Xsolis announced today that it has been selected as a finalist in the Fierce Innovation Awards – Healthcare Edition 2020, a peer-reviewed awards program from the publisher of Fierce Healthcare, produced by Questex.The competition highlights companies that demonstrated innovative solutions that have had the greatest potential to save money, engage patients, or revolutionize the industry over the past 12 months. Xsolis was recognized as a finalist in the category of Financial/Operational Solutions.
Xsolis was selected as a finalist for its solution, CORTEX, the Precision Utilization Management Platform now known as Dragonfly. Dragonfly creates a utilization management network between payers and providers for data-driven, clinically-centered medical necessity determinations.
The awards program’s applications were reviewed by an exclusive panel of executives from major healthcare companies including Accenture Health, Aspirus, Inc., Aveus, a Division of Medecision, Cook Children’s Health Care System, Duncan Regional Hospital, Evolution Road, GNS Healthcare, Hackensack Meridian Health, HMS, Proliance Surgeons and Author, The Health Care Consumers Manifesto. All applications were evaluated based on the following criteria: effectiveness, technical innovation, competitive advantage, financial impact, and true innovation. A full list of judges can be found at fiercehealthcareawards.secure-platform.com/a/page/judges.
Winners will be announced in the 2020 Innovation Report set to publish by Fierce Healthcare on Monday, September 14, 2020.